Journal of Multiple Sclerosis and Neuroimmunology

Search

Page Path

HOME
Search

Review Article

Summary of Cladribine (from Development to Clinical and Practical Treatment): Kyong Jin Shin; J Mult Scler Neuroimmunol. 2024;15(2):55-58. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.55-58; Full text PubReader ePub PDF

Original Article

Contemporary Patterns of High-Efficacy Disease Modifying Therapy Use in Korean Patients with Relapsing-Remitting Multiple Sclerosis: Su-Hyun Kim, Na Young Park, Min Jeong Kim, Ki Hoon Kim, Jae-Won Hyun, Ho Jin Kim; J Mult Scler Neuroimmunol. 2023;14(2):99-105. Published online December 31, 2023; DOI: https://doi.org/10.59578/jmsni.2023.14.2.99; Full text PubReader ePub PDF

Review Article

Recent Clinical Trials of Multiple Sclerosis: Jae Young An, Kwang Soo Lee; J Mult Scler Neuroimmunol. 2010;1(1):6-11. Published online March 1, 2010; PDF

Volume 16, No. 2

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

3,361	Autoimmune Nodopathy: When to Suspect and How to Treat?
3,020	National Consensus Guidance for Management of Refractory Myasthenia Gravis
2,113	Monoclonal Antibody Treatment for Relapse Prevention in Neuromyelitis Optica Spectrum Disorder
1,959	Clinicoradiological Factors for Predicting and Monitoring the Progression of Multiple Sclerosis
1,521	Severe Neutropenia Following Rituximab Treatment in Patients with Multiple Sclerosis

Cited By 1	National Consensus Guidance for Management of Refractory Myasthenia Gravis
Cited By 1	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as a Diffuse Pachymeningitis

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: jmsni@koreams.org

Copyright © 2026 by Korean Society of Neuroimmunology.